Evolution of discrepancies in limb asymmetry in Beckwith–Wiedemann spectrum
Open Access
- 15 October 2025
- journal article
- Published by SAGE Publications in Journal of Children's Orthopaedics
Abstract
Background: Beckwith–Wiedemann spectrum is a genetic disorder characterized by lateralized overgrowth, often presenting as limb bulk discrepancy. While limb-length discrepancies are documented in Beckwith–Wiedemann spectrum, the natural history of limb bulk discrepancy and hand/foot asymmetry progression remains less studied. This research examines limb bulk discrepancy progression in children with Beckwith–Wiedemann spectrum and identifies factors influencing its severity. Methods: A retrospective, single-institution study analyzed 142 children with molecularly confirmed Beckwith–Wiedemann spectrum (imprinting center 2 loss of methylation, imprinting center 1 gain of methylation, and paternal uniparental isodisomy at chromosome 11). Limb measurements (upper arm, forearm, thigh, calf, palm, finger, and foot) were recorded during clinic visits. Linear mixed-effects models assessed relationships between genotype, age, limb bulk discrepancy progression, body mass index, and sex. Results: The cohort included 90 imprinting center 2 loss of methylation, 41 paternal uniparental isodisomy at chromosome 11, and 11 imprinting center 1 gain of methylation patients. In the imprinting center 2 loss of methylation group, significant limb bulk discrepancy progression occurred in the upper arm (0.47 mm/year), calf (0.53 mm/year), and foot anterior–posterior dimension (0.40 mm/year; all p < 0.01). The paternal uniparental isodisomy at chromosome 11 genotype showed greater asymmetry in most regions compared to others ( p < 0.01), except the middle finger. Asymmetry progression rates were similar across genotypes. Body mass index positively correlated with increased limb bulk discrepancy in the upper arm and calf. Conclusions: Limb asymmetry in Beckwith–Wiedemann spectrum progresses slowly in specific regions, with genotype and body mass index influencing baseline severity. Patients with paternal uniparental isodisomy at chromosome 11 exhibit greater baseline limb bulk discrepancy, but progression rates are consistent across genotypes, highlighting the need for further research into lateralized overgrowth mechanisms and clinical implications. Level of evidence: 3—Retrospective cohort study.Keywords
Funding Information
- Victoria Fertitta Fund through the Lorenzo “Turtle” Sartini Jr. Endowed Chair in Beckwith–Wiedemann Syndrome Research
This publication has 25 references indexed in Scilit:
- Nomenclature and definition in asymmetric regional body overgrowthAmerican Journal of Medical Genetics Part A, 2017
- Cancer Risk in Beckwith-Wiedemann Syndrome: A Systematic Review and Meta-Analysis Outlining a Novel (Epi)Genotype Specific Histotype Targeted Screening ProtocolThe Journal of Pediatrics, 2016
- Phenotype, cancer risk, and surveillance in Beckwith–Wiedemann syndrome depending on molecular genetic subgroupsAmerican Journal of Medical Genetics Part A, 2016
- Recommendations of the Scientific Committee of the Italian Beckwith–Wiedemann Syndrome Association on the diagnosis, management and follow-up of the syndromeEuropean Journal of Medical Genetics, 2016
- (Epi)genotype–phenotype correlations in Beckwith–Wiedemann syndromeEuropean Journal of Human Genetics, 2015
- Methylation analysis and diagnostics of Beckwith-Wiedemann syndrome in 1,000 subjectsClinical Epigenetics, 2014
- Clinical utility gene card for: Beckwith–Wiedemann SyndromeEuropean Journal of Human Genetics, 2013
- Molecular subtypes and phenotypic expression of Beckwith–Wiedemann syndromeEuropean Journal of Human Genetics, 2005
- Epigenetic Alterations of H19 and LIT1 Distinguish Patients with Beckwith-Wiedemann Syndrome with Cancer and Birth DefectsThe American Journal of Human Genetics, 2002
- Proportion of cells with paternal 11p15 uniparental disomy correlates with organ enlargement in Wiedemann-beckwith syndrome.2000